4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
13.67
-0.17 (-1.23%)
Oct 2, 2026, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $755.19 million as of October 2, 2026. Its market cap has increased by 85.23% in one year.
Market Cap
755.19M
Enterprise Value
363.78M
1-Year Change
85.23%
Ranking
Category
Stock Price
$13.67
ChartMarket Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $755.19M, an increase of 30.12%. That is a compound annual growth rate of 4.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 755.19M | 76.23% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexon | 794.34M |
| Attovia Therapeutics | 783.83M |
| Candel Therapeutics | 778.96M |
| Design Therapeutics | 772.26M |
| Geron | 770.97M |
| Gyre Therapeutics | 753.90M |
| Achieve Life Sciences | 745.01M |
| Wave Life Sciences | 744.84M |